Biogen Inc. plans to soon increase its ownership stake in biosimilars maker Samsung Bioepis Co. Ltd., anticipating quickening sales of the copycat biologics developed by the Korean pharma.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,